Altamira Therapeutics Ltd (FRA:2QA)
€ 948 0 (0%) Market Cap: 1.45 Mil Enterprise Value: 1.79 Mil PE Ratio: 0.84 PB Ratio: 0.17 GF Score: 28/100

Q4 2020 Auris Medical Holding Ltd Earnings Call Transcript

Apr 13, 2021 / 12:00PM GMT
Release Date Price: €1346.4 (-14.83%)
Operator

Good day, and thank you for standing by. And welcome to the Auris Medical to Provide Business Updates on AM-301 Program Call. (Operator Instructions) I must advise you that this call is being recorded today, Tuesday, the 13th of April 2021. (Operator Instructions)

And earlier today, Auris Medical issued a news release announcing preclinical and clinical outcomes with AM-301 and detailing plans for market launch. The release is available on the company's website aurismedical.com and filed with the SEC.

During today's call, Auris Medical will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating, financial or business performance or the company's strategies or expectations. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that cause -- that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks are -- these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot